LSBio
GADD45GIP1 / CRIF1 Antibody (aa91-140)

Immunohistochemistry analysis of paraffin-embedded human brain, using GADD45GIP1 Antibody. The picture on the right is blocked with the synthesized peptide.

GADD45GIP1 / CRIF1 Antibody (aa91-140)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all Human GADD45GIP1 / CRIF1 antibodies →
$341.00each
Catalog Number: LS-C120010-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
CRIF1 antibody LS-C120010 is an unconjugated rabbit polyclonal antibody to human CRIF1 (GADD45GIP1) (aa91-140). Validated for IHC and Peptide-ELISA. Cited in 1 publication.
Application
ELISA, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CR6 interacting factor 1 | CR6-interacting factor 1 | p53-responsive gene 6 protein | PLINP-1 | PLINP | Plinp1 | CKBBP2 | CKII beta binding protein 2 | CKII beta-associating protein | CRIF1 | GADD45GIP1 | PRG6
UniProt Number
Q8TAE8
SwissProt
Q8TAE8

Target

Target
Human GADD45GIP1 / CRIF1
Antigen Species
Human
Epitope
GADD45GIP1 Antibody detects endogenous levels of total GADD45GIP1 protein.
Gene Name
GADD45GIP1

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Synthetic peptide from human GADD45GIP1. (AA Range: 91-140)
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS (without Mg2+, Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol
Concentration
1 mg/mL
Volume
50 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year.
Recommended Storage Buffer
PBS|150 mM NaCl
Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer. Nakayama K, Rahman M, Rahman MT, Nakamura K, Sato E, Katagiri H, Ishibashi T, Ishikawa M, Iida K, Razia S, Ishikawa N, Kyo S. Oncology letters. 2017;13:4713-4719. PubMed: 28599472 PMC: PMC5453174

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.